Corporate

Management Team
Board of Directors
Corporate Governance



Board of Directors

The Company's Board of Directors is comprised of individuals with public Company and life science industry expertise. The current Board of the Company consists of the following individuals.

Chung-Yu Wang, B.Sc., SIMP Diploma
Co-founder, Chairman of the Board, Director and Interim President

Mr. Wang is our co-founder and has been Chairman of the board of directors and a director of the Company since its incorporation in April 2004. Mr. Wang acted as Interim Chief Executive Officer from October 2008 to August 2009 and has been Interim President since October 2008. Mr. Wang has extensive experience in the area of public Company management, international business development and corporate restructure. Mr. Wang currently serves as Chairman of China Coal and Coke Investment Holding Company Limited and Vice Chairman of Tong Lung Metal Industry Co., Ltd. ("Tong Lung Metal"). Mr. Wang was Chairman of Tong Lung Metal from 2002 to June 2007 and Chairman of the China Steel Corporation from 1972 to 2001. Mr. Wang also previously served as Chairman of International Iron Institute and the Taiwan Steel and Iron Industries Association.
Mr. Wang received his SIMP Diploma from Harvard University, and Bachelor of Engineering in Chemical from Chung Yuan University, Taiwan. He was also granted an honorary Ph. D. Degree in Chemical Engineering by Chung Yuan University, Taiwan.

Tsong Chin Lin
Vice Chairman and Director

Mr. Lin has been a director of the Company since April 2009. Mr. Lin brings over 30 years of extensive experience in general management and operation management with leading industrial technology companies. Mr. Lin currently serves as the Chief Executive Officer at General Biologicals Corporation. Prior to his promotion at General Biologicals Corporation, he was the Chief Strategy Officer from 2007 to 2009 and Chairman from 1994 to 2007. Mr. Lin was the Chief Executive Officer of Megamedia Corporation for 20 years. Prior to these, Mr. Lin was involved in various leadership roles at General Instrument of Taiwan Ltd.

Mr. Lin received his diploma from the Taipei Institute of Technology, Taiwan.

Ming S. Liu, Ph.D,
Director and Chief Executive Officer (CEO)

Dr. Liu possesses more than 15 years of diversified experience in bio-products development, sales and marketing, business development, and operational management. He was previously the founder and CEO of eGene, Inc. a biotech company based in Irvine, California, and positioned the company for acquisition by QIAGEN (NASDAQ: QGEN) in 2007

Mr. Lin received his Ph.D. in Biology from the University of British Columbia, Vancouver, BC.

John Hsuan
Director

Mr. Hsuan is an established business leader in Taiwan and brings to Pacgen a wealth of entrepreneur experience. His extensive background includes global operation management, international business development and venture capital experience. Mr. Hsuan has incubated and co-founded more than 20 public companies. He currently serves as Chairman of NCTU Venture Capital, Ltd., NTCU Spring Venture Capital Co., Ltd., Maxima Capital Management, Inc., as well as Faraday Technology Corporation. Mr. Hsuan also currently serves as the Emeritus Vice Chairman of United Microelectronic Corporation ("UMC"), a leading global semiconductor foundry traded on the New York Stock Exchange and the Taiwan Stock Exchange. During his tenure with UMC for over 20 years, he held several senior positions including Chief Executive Officer, Chairman and Vice-Chairman.

Mr. Hsuan holds a Bachelor Degree in Electronic Engineering and an Honorary Ph.D. Degree from National Chiao Tung University in Taiwan. He has received numerous business achievement awards in Taiwan, and has been awarded 44 patents in USA and 41 patents in Taiwan.

Telvin Ju, Ph.D.
Director

Dr. Ju has been a director of the Company since October 2004. Dr. Ju is currently the Senior Vice President of Chinese Maritime Transport Ltd. Chinese Maritime Transport, Ltd. is listed on the Taiwan Stock Exchange. A key part of his role at the Associated Group is to advise and consult for various venture capital and asset management companies on investments in Greater China and Biotechnology. He was previously a research associate at Johns Hopkins University in the Chemistry Department.

Dr. Ju received his Ph.D. in Biochemistry and Bachelor of Science in Chemistry and Biology from the University of Miami, Florida.

Fred Huang, BA, MBA
Co-founder and Director

Mr. Huang is the co-founder of the Company and has been a director since August 2009. Mr. Huang was Senior Vice President and Chief Operating Officer ("COO") of the Company from April 2006 to February 2009. Prior to his promotion to Senior Vice President and COO, Mr. Huang served as Chief Financial Officer ("CFO") and Secretary from April 2004 to April 2006. Mr. Huang has extensive North American and Asian business experiences. Prior to joining Pacgen, Mr. Huang was the CFO of Cytocan Biotechnology Inc. from 2002 to 2004. He was Senior Financial Advisor with Canadian Imperial Bank of Commerce Investor Services Inc. ("CIBC") where he built and managed a $150 million portfolio from 1997 to 2002. Prior to joining CIBC, Mr. Huang held various senior management positions with President Asian Enterprises Inc., Klockner Steel Corporation (Germany), and China Steel Corporation.

Mr. Huang received his Masters of Business Administration degree from the University of Southern California and Bachelor of Engineering (Metallurgical) degree from the National Taipei Technology University, Taiwan.

Jeng-Horng Her, Ph.D.
Director

Dr. Jeng-Horng Her, brings to Pacgen extensive experience in the life science sector. He is currently the Chief Executive Officer of ProtevoBio Inc. (ProtevoBio). Prior to forming ProtevoBio in September 2006, Dr. Her co-founded KaloBios Pharmaceuticals, Inc., a therapeutic antibody company in South San Francisco, CA that has raised US$76 million in private financing since its inception in 2001 where he was responsible for all clinical and regulatory activities.

Dr. Her obtained his Ph.D. in Microbiology and Immunology from the University of Virginia, Charlottesville, VA, USA.